Royal Bank Of Canada Pacira Bio Sciences, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 234,332 shares of PCRX stock, worth $4.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
234,332
Previous 213,481
9.77%
Holding current value
$4.84 Million
Previous $6.11 Million
42.21%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PCRX
# of Institutions
263Shares Held
50.4MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$165 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$109 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$102 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$41.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$40.8 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $946M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...